All News

Check out this list of our top 5 most read infectious disease stories from the year 2024.

Check out this list of our top 5 most read pain management stories from the year 2024.

Check out this list of our top 5 most read cardiology stories from the year 2024.

Check out this list of our top 5 most read digestive health stories from the year 2024.

Check out this list of our top 5 most read Total Pharmacy stories from the year 2024.

Check out this list of our top 5 most read COVID-19 stories from the year 2024.

Check out this list of our top 5 most read Drug Topics stories from the year 2024.

Provisions under the Inflation Reduction Act have ensured cost savings for patients prescribed drugs covered under Medicare Part B.

Senators Elizabeth Warren and Tina Smith have reintroduced the Pharmaceutical Supply Chain Defense and Enhancement Act originally established in 2020.

Researchers reviewed Medicaid policies to understand vaccine coverage and reimbursement rates among physicians and pharmacists.

A conversation with Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences.

Researchers explored the impacts of natural bioactive compounds for the treatment of acute pancreatitis.

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

Authors concluded that that the benefit of the vaccine in preventing long COVID is due mainly to the fact it mitigates the risk of infection.

Although the drug fell short of its 25% expected weight loss, results are still promising for people with overweight or obesity.

With pressure from the House GOP, expected PBM reform was not included in Congress’ end-of-year spending package.

Recent upticks of the bird flu virus in both dairy cattle and humans have also led to a state of emergency in California.

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

MannKind announced results from the INHALE-1 study that examined Afrezza in children and adolescents with diabetes.

The American Pharmacists Association announced the inclusion of pharmacist-backed PBM reform in Congress’ end of the year spending package.

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic, discusses her career and how biosimilars will impact the pharmacy profession in the coming years.

Student pharmacists who wore a continuous glucose monitor had a higher average counseling score during an encounter with a patient and a higher overall confidence score.

A conversation with Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic.

Triptans are used to treat acute migraine and cluster headaches.

Treatment of comorbidities may help patients overcome resistance or refractoriness to migraine therapies.

Drug Topics met with Lourdes Cross, PharmD, BCACP, CDCES, to discuss pharmacists’ role in managing patients’ chronic obstructive pulmonary disease.

Two posters presented at the meeting looked into the topic CGMs in diabetes care.

Experts conducted a study to better understand how ambulatory care pharmacist services impacted patient outcomes, provider workload, and access to care.